Results 101 to 110 of about 570,978 (229)

Three Challenging Cases of Autoimmune Encephalitis: A Case‐Series and a Review of the Literature

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT This manuscript highlights the importance of considering autoimmune encephalitis in patients presenting with multisystem symptoms that cannot be explained by a single neurological condition. Early inclusion of autoimmune encephalitis in the differential diagnosis can help avoid unnecessary treatments and reduce overall healthcare costs.
Mohammad Ali Bahramy   +2 more
wiley   +1 more source

Oral Microbiota and Inflammatory Bowel Diseases: Detection of Emerging Fungal Pathogens and Herpesvirus

open access: yesBiomedicines
Background/Objectives: Ulcerative colitis (UC) and Crohn’s disease (CD) are the usual clinical forms of inflammatory bowel disease (IBD). Changes in the oral microbiota, especially the presence of emerging fungi and herpesviruses, have been shown to ...
Manoel Marques Evangelista Oliveira   +11 more
doaj   +1 more source

Herpes Simplex Virus Infection With Multiple Cerebral Hemorrhages: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Herpes simplex virus (HSV) infection may trigger rare vascular complications that lead to multiple cerebral hemorrhages. This case emphasizes considering HSV in unexplained cerebral hemorrhage among immunocompromised individuals with systemic symptoms, as timely antiviral treatment effectively improves clinical outcomes.
Zhongzhan Wu   +4 more
wiley   +1 more source

Human herpesvirus 7 and lymphocytic leukaemia [PDF]

open access: yesBritish Journal of Haematology, 1999
M, Daibata   +4 more
openaire   +2 more sources

Toward Anti‐Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma‐Associated Herpesvirus Latency‐Associated Nuclear Antigen

open access: yesChemMedChem, Volume 21, Issue 1, January 2026.
It is attempted to employ proteolysis‐targeting chimeras‐based targeted protein degradation to the viral protein “Latency‐associated Nuclear Antigen” from Kaposi's sarcoma‐associated herpesvirus. While ternary complex formation is detected via native mass spectrometry, protein degradation is not observed, presumably due to insufficient permeability ...
Aylin Berwanger   +10 more
wiley   +1 more source

Human Herpesvirus 7 and Pityriasis Rosea [PDF]

open access: yesJournal of Investigative Dermatology, 1999
Watanabe, Takahiro   +3 more
openaire   +2 more sources

Human herpesvirus 6 and 7

open access: yes, 2016
Human herpesvirus 6 (HHV-6) and 7 (HHV-7) constitute the roseolavirus group of β-herpesviruses. HHV-6 has two subtypes HHV-6A and HHV-6B. Both HHV-6 and HHV-7 tend to produce mild self-limiting illness in immunocompetent children that typically develops in late infancy and early childhood. HHV-6, in particular, is associated with a viral exanthem known
openaire   +1 more source

Practical implications of the World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Categories and ancillary testing for subtyping of hematolymphoid tumors on FNA biopsy cytopathology using a pattern‐based approach

open access: yesCancer Cytopathology, Volume 134, Issue 1, January 2026.
Abstract The objective of the recently published World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology (WHO system) is to standardize the diagnostic approach to fine‐needle aspiration biopsies of hematolymphoid tissues.
Mats Ehinger   +4 more
wiley   +1 more source

Identification of Potential Ferroptosis Biomarkers in Multiple Myeloma via WGCNA and Experiments

open access: yesCancer Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Multiple myeloma is a common malignant tumor of the hematologic system, and genetic alterations play a crucial role in its occurrence and development. Ferroptosis is an oxidative and iron‐dependent programmed cell death, which has a strong correlation with tumor development.
Yifan Wang   +7 more
wiley   +1 more source

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 1, January 2026.
Abstract Venanprubart (LY3361237), an agonist antibody to B and T lymphocyte attenuator (BTLA), was developed as a potential treatment for autoimmune disorders, including systemic lupus erythematosus (SLE) and psoriasis. We tested venanprubart in three human Phase 1 safety studies: a single ascending dose (SAD) study in healthy participants (1/2/5/15 ...
Andrew C. Vendel   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy